VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $178 | -29.6% | 23,025 | +4.1% | 0.00% | – |
Q2 2023 | $253 | +178.0% | 22,126 | +86.5% | 0.00% | – |
Q1 2023 | $91 | +85.7% | 11,866 | +46.7% | 0.00% | – |
Q4 2022 | $49 | -99.9% | 8,091 | -21.3% | 0.00% | – |
Q3 2022 | $60,000 | 0.0% | 10,283 | 0.0% | 0.00% | – |
Q2 2022 | $60,000 | -55.2% | 10,283 | -41.8% | 0.00% | – |
Q1 2022 | $134,000 | +605.3% | 17,678 | +144.7% | 0.00% | – |
Q4 2021 | $19,000 | +26.7% | 7,223 | +21.0% | 0.00% | – |
Q3 2021 | $15,000 | -58.3% | 5,970 | -33.2% | 0.00% | – |
Q2 2021 | $36,000 | – | 8,940 | +4922.5% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 178 | -98.5% | 0.00% | – |
Q4 2020 | $86,000 | +473.3% | 12,102 | +1225.5% | 0.00% | – |
Q3 2019 | $15,000 | -96.9% | 913 | -96.4% | 0.00% | -100.0% |
Q1 2018 | $482,000 | +44.3% | 25,658 | +27.2% | 0.00% | 0.0% |
Q4 2017 | $334,000 | – | 20,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |